Structure details positive trial data for a weight-loss pill, and the stock rockets
Up next
Author


Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron, that just showed positive results from a Phase 2 trial.

You May Also Like
A used car for $30,000 is now a ‘bargain’? How to get a good one for less.

A used car for $30,000 is now a ‘bargain’? How to get a good one for less.

Years of price increases that started during the pandemic have led to…
Dow Transports are stock-market leaders now. Here’s what that means for investors.

Dow Transports are stock-market leaders now. Here’s what that means for investors.

Dow Transportation index is considered a bellwether for the broad market —…

Keir Starmer says his government must be ‘prepared to be unpopular’

Sir Keir Starmer has said his government is “going to have to…
How Morgan Stanley’s bearish strategist may be right for the wrong reason

How Morgan Stanley’s bearish strategist may be right for the wrong reason

Surely everyone’s contrarian impulses were triggered by the sight of the guy…